Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Ciprofloxacin Extended-Release 1000 mg Once-Daily Versus Ciprofloxacin Immediate-Release 500 mg Twice-Daily Given 7-14 Days in Patients With Complicated Urinary Tract Infections: Prospective, Randomized, Double-Blind Trial.

NCT00668122 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00668122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00668122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Ciprofloxacin Extended-Release 1000 mg Once-Daily Versus Ciprofloxacin Immediate-Release 500 mg Twice-Daily Given 7-14 Days in Patients With Complicated Urinary Tract Infections: Prospective, Randomized, Double-Blind Trial.
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
January 31, 2006
Enrollment
212 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

urinary tract infection